Early results of one-stage septic revision arthroplasties with antibiotic-laden cement. A clinical and statistical analysis;Frühergebnisse des einzeitigen septischen TEP-Wechsel mit antibiotikahaltigem knochenzement. Klinische und statistische analyse

Orthopade

Volumn 34, Issue 6, 2005, Pages 592-601

  Sofer, D ^a   Regenbrecht, B ^b   Pfeil, J ^c  

^a KLINIKUM DARMSTADT   (Germany)

^b DR HORST SCHMIDT KLINIKEN   (Germany)

^c ST JOSEFS HOSPITAL   (Germany)

Author keywords

Antibiotic laden cement; Clinical study; One stage arthroplasty; Periprosthetic infection; Statistical comparison

Indexed keywords

ANTIBIOTIC AGENT; CEMENT;

ARTHROPLASTY; ARTICLE; COST EFFECTIVENESS ANALYSIS; ERADICATION THERAPY; HIP; HOSPITALIZATION; HUMAN; KNEE; KNEE ARTHROPLASTY; MORBIDITY; PATIENT SATISFACTION; PROSTHESIS; PROSTHESIS INFECTION; REOPERATION; SEPSIS; STATISTICAL ANALYSIS; STOCHASTIC MODEL; SURGEON; TREATMENT OUTCOME;

ANTI-BACTERIAL AGENTS; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; BONE CEMENTS; DELAYED-ACTION PREPARATIONS; GERMANY; HUMANS; LENGTH OF STAY; PATIENT SATISFACTION; PILOT PROJECTS; PROSTHESIS-RELATED INFECTIONS; RECOVERY OF FUNCTION; REOPERATION; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME;

EID: 21644473584     PISSN: 00854530     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00132-005-0780-2     Document Type: Article

References (30)

1. Antti-Poika I, Santavirta S, Konttinen YT, Honkanen V (1989) Outcome of the infected hip arthroplasty. A retrospective study of 36 patients. Arch Orthop Scand 60: 670-675
2. Arens S, Kutscha-Lissberg F, Hebler U, Wingenfeld C, Kälicke T, Muhr G (2002) Der pyogene Infekt nach Gelenkersatzoperation: Inzidenz und ökonomische Auswirkungen. Kongressbd Dtsch Ges Chir Kongr 119: 738-742
3. Armstrong MS, Spencer RF, Cunningham JL, Gheduzzi S, Miles AW, Learmonth ID (2002) Mechanical characteristics of antibiotic-laden bone cement. Acta Orthop Scand 73: 688-690
4. Bengtson S, Knutson K (1991) The Infected Knee Arthroplasty. Acta Orthop Scand 62: 301-311
5. Bernard L, Hoffmeyer P, Assal M, Vaudaux P, Schrenzl J, Lew D (2003) Trends in the treatment of orthopaedic prosthetic infections. J Antimicrobial Chemother 19
6. Borden LS, Gearen PF (1987) Infected total knee arthroplasty. A protocol for management. J Arthroplasty 2: 27-36
7. Callaghan JJ, Katz R, Johnson RC (1999) One-stage revision surgery of the infected hip. A minimum 10-year follow-up study. Clin Orthop 369: 139-143
8. Cramer J, Ekkernkamp A, Ostermann PAW (2001) Die infizierte Endoprothese am Beispiel der Hüftendoprothese. Eine zunehmende Gefahr für Patienten und Gesellschaft. Z Ärztl Fortbild Qualitätssich (ZaeFQ) 95: 195-201
9. Elson R (1994) One-stage exchange in the treatment of the infected total hip. Sem Arthroplasty 5: 137-141
10. Fackler CD, Poss R (1980) Dislocation in total hip arthroplasties. Clin Orthop 151: 169
11. Garvin KL, Evans BG, Salvati EA, Brause BD (1994) Palacos Gentamicin for the treatment of deep periprosthetic hip infections. Clin Orthop 298: 97-105
12. Gehrke T, Förster v G, Frommelt L (2001) Pharmakinetic study of a Gentamicin/Clindamicin bone cement used in one-stage revision arthroplasty. In: Walenkamp GHIM, Murray DW (eds) Bone cements and cementing technique. Springer, Berlin Heidelberg New York Tokio, pp 127-134
13. Göksan SB, Freeman MAR (1992) One-stage reimplantation for infected total knee arthroplasty. J Bone Joint Surg Br 74: 78-82
14. Gristina AG (1987) Biomaterial-centred infection: Microbial adhesion versus tissue integration. Science 237: 1588-1595
15. Haddad FS, Muirhead-Allwood SK, Manktelow ARJ, Bacarese-Hamilton I (2000) Two-stage uncemented revision hip arthroplasty for infection. J Bone Joint Surg Br 82: 689-694
16. Hanssen AD, Rand JA (1999) Evaluation and treatment of infection at the site of a total hip or knee artroplasty. AAOS Instruct Course Lect 48: 111-122
17. Härle A (1989) Infection management in total hip replacement. Arch OrthopTrauma Surg 108: 63-71
18. Insall JN, Dorr LD, Scott R, Scott WN (1989) Rationale of the Knee Society Clinical Rating System. Clin Ortop 248: 13-14
19. Jackson WO, Schmalzried TP (2000) Limited role of direct exchange arthroplasty in the treatment of infected total hip replacement. Clin Orthop 381: 101-105
20. Lidgren L (2001) Joint prothetic infections: A success story. Acta Orthop Scand 72 (6): 553-556
21. Merle d'Aubigné R, Postel M (1954) Functional results of arthroplasty with acrylic prothesis. J Bone Joint Surg Am 36: 451-475
22. Raut W, Siney PD, Wroblewski BM (1994) One-stage revision of infected total hip replacements with discharging sinuses. J Bone Joint Surg Br 76: 721-724
23. Regenbrecht B (2002) Luxation nach Hüftgelenksendoprothesen. Medizinische Dissertation, Universität Kiel
24. Robbins GM, Mari BA, Garbuz DS, Duncan CP (2001) Primary total hip arthroplasty after infection. AAOS Instr Course Lect 50: 317-333
25. Sculco TP (1995) The economic impact of infected joint arthroplasty. Orthopedics 18: 871-873
26. Steinbrink K, Frommelt L (1995) Behandlung der periprothetischen Infektion der Hüfte durch einzeitige Austauschoperation. Orthopäde 24: 335-343
27. Woo RYG, Morrey (1982) Dislocation after total hip arthroplasty. J Bone Joint Surg Am 64: 1295-1306
28. Wroblewski BM (1986) One-stage revision of infected cement total hip arthroplasty. Clin Orthop 211: 103-107
29. Ure KJ, Amstutz HC, Nasser S, Schmalzried TP (1998) Direct-exchange arthroplasty for treatment of infection after total hip replacement. J Bone Joint Surg Am 80: 961-968
30. Younger ASE, Duncan CP, Masri BA, McGraw RW (1997) The outcome of two-stage arthroplasty using a custom-made interval spacer to treat the infected hip. J Arthroplasty 12: 615-623